13. Prevention of Recurrent Mucinous Borderline Ovarian Tumor with Aromatase Inhibitor
We present a case of progression from mucinous cystadenoma to mucinous BOT after two prior cystectomies in whom an AI was used and the patient is now 2 years without recurrent disease.
Source: Journal of Pediatric and Adolescent Gynecology - Category: OBGYN Authors: Kathryn Stambough, Jodi Muscal, Creighton Edwards, Jennifer Dietrich Source Type: research